Allosteric proteins after thirty years: the binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors
- PMID: 8988250
- DOI: 10.1007/BF01952106
Allosteric proteins after thirty years: the binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors
Abstract
A key statement of the 1965 Monod-Wyman-Changeux (MWC) model for allosteric proteins concerns the distinction between the ligand-binding function (Y) and the relevant state function (R). Sequential models predict overlapping behavior of the two functions. In contrast, a straightforward experimental consequence of the MWC model is that for an oligomeric protein the parameters which characterize the two functions should differ significantly. Two situations, where R > Y and the system is hyper-responsive or where R < Y and the system is hypo-responsive, have been encountered. Indeed, the hyper-responsive pattern was first observed for the enzyme aspartate transcarbamoylase, by comparing Y with R monitored by a change in sedimentation. Extensions of the theory to ligand-gated channels led to the suggestion that, on the one hand, hyper-responsive properties also occur with high-affinity mutants. On the other hand, native channels of the acetylcholine neuronal alpha 7 receptor and low-affinity mutants of the glycine receptor can be interpreted in terms of the hypo-responsive pattern. For the ligand-gated channels, whereas R is detected directly by ion flux, ligand binding has rarely been measured and the formation of desensitized states may complicate the analysis. However, stochastic models incorporating both binding and channel opening for single molecules predict differences that should be measurable with new experimental approaches, particularly fluorescence correlation spectroscopy.
Similar articles
-
Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo-Steady-State Responses from GABAA Receptors.Mol Pharmacol. 2019 Jan;95(1):106-119. doi: 10.1124/mol.118.113787. Epub 2018 Oct 17. Mol Pharmacol. 2019. PMID: 30333132 Free PMC article. Review.
-
Nicotinic receptors: From protein allostery to computational neuropharmacology.Mol Aspects Med. 2022 Apr;84:101044. doi: 10.1016/j.mam.2021.101044. Epub 2021 Oct 13. Mol Aspects Med. 2022. PMID: 34656371 Review.
-
A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions.Biol Cybern. 1996 Nov;75(5):361-79. doi: 10.1007/s004220050302. Biol Cybern. 1996. PMID: 8983160
-
Monod-Wyman-Changeux Analysis of Ligand-Gated Ion Channel Mutants.J Phys Chem B. 2017 Apr 20;121(15):3813-3824. doi: 10.1021/acs.jpcb.6b12672. Epub 2017 Feb 21. J Phys Chem B. 2017. PMID: 28134524 Free PMC article.
-
A solution NMR study showing that active site ligands and nucleotides directly perturb the allosteric equilibrium in aspartate transcarbamoylase.Proc Natl Acad Sci U S A. 2007 May 22;104(21):8815-20. doi: 10.1073/pnas.0703347104. Epub 2007 May 14. Proc Natl Acad Sci U S A. 2007. PMID: 17502625 Free PMC article.
Cited by
-
GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC50 and Basal Activity.Mol Pharmacol. 2018 Feb;93(2):90-100. doi: 10.1124/mol.117.110569. Epub 2017 Nov 17. Mol Pharmacol. 2018. PMID: 29150461 Free PMC article.
-
Structural basis of activation of cys-loop receptors: the extracellular-transmembrane interface as a coupling region.Mol Neurobiol. 2009 Dec;40(3):236-52. doi: 10.1007/s12035-009-8084-x. Epub 2009 Oct 28. Mol Neurobiol. 2009. PMID: 19859835 Review.
-
The role of Loop F in the activation of the GABA receptor.J Physiol. 2010 Jan 1;588(Pt 1):59-66. doi: 10.1113/jphysiol.2009.179705. J Physiol. 2010. PMID: 20045907 Free PMC article. Review.
-
Allosteric activation mechanism of the cys-loop receptors.Acta Pharmacol Sin. 2009 Jun;30(6):663-72. doi: 10.1038/aps.2009.51. Epub 2009 May 11. Acta Pharmacol Sin. 2009. PMID: 19444220 Free PMC article. Review.
-
Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo-Steady-State Responses from GABAA Receptors.Mol Pharmacol. 2019 Jan;95(1):106-119. doi: 10.1124/mol.118.113787. Epub 2018 Oct 17. Mol Pharmacol. 2019. PMID: 30333132 Free PMC article. Review.